PCRX as of Nov 2 · 19:10 ET

PCRXNasdaqPharmaceutical Preparations

Pacira BioSciences, Inc. · Brief

Next report

2 days

Nov 5 · after closeest.Q3 FY26

Earnings

Expected move

Inputs

±2.6%implied · report alone

35.4537.35

straddle ±4.8%

spot 36.40exp Nov 20ATM strike 37.5ATM straddle 2.07IV 27%

Nov 2 closereport share · term structure

Expected move

Inputs

Implied vs realized

8 reportsHistory

1 of 8≥ implied

avg implied: ±11.4%
avg realized: ±4.7%

Feb 27 '25±11.5%▼−5.24%×0.46

May 8 '25±7.5%▲+0.84%×0.11

Aug 5 '25±10.2%▼−0.62%×0.06

Nov 6 '25±16.1%▲+4.50%×0.28

Jan 8 '26±15.8%▼−9.57%×0.61

Feb 26 '26±11.0%▼−3.01%×0.27

Q1 FY26±10.0%▼−4.12%×0.41

Q2 FY26±9.3%▼−9.96%×1.08

quarterimplied−20%0+20%realized×

Q2 FY26±9.3%▼−9.96%×1.08

Q1 FY26±10.0%▼−4.12%×0.41

Feb '26±11.0%▼−3.01%×0.27

Jan '26±15.8%▼−9.57%×0.61

Nov '25±16.1%▲+4.50%×0.28

Aug '25±10.2%▼−0.62%×0.06

2 older reports

May '25±7.5%▲+0.84%×0.11

Feb '25±11.5%▼−5.24%×0.46

Shaded = implied · tick ▲▼ = realized · × = |realized| ÷ impliedSource: options EOD · implied at prior close · realized close to close

Bull & bear

Nov 5 report · est.

Bull1

12disclosed supplier and customer ties in SEC filingsSEC filings

Bear2 of 4

31.00%of revenue from the largest disclosed customer, McKesson Drug CompanySEC filings

7 of 8recent reports where the move came in under the options-implied rangeEarnings history

AI captions · Sep 16 '26once per report · top 2 per case

Linked exposure

PCRX report session

No linked exposure.

Latest changes

30 daysAll changes

Oct 22impliedImplied move: ±1.6% into Nov 5 earnings (Oct 22 close).Source

Oct 88-KMaterial agreement: Agreement and Plan of Merger with Viatris Inc.Source

Oct 8haltTrading halt: 07:40 ET, resumed 08:05 ET.Source

Your note

privateThesis 0 · Decisions 0 · Observations 0

No thesis.